Sun, Dec 28, 2014, 9:56 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Celgene Corp. (CELG) Message Board

  • rob_cos rob_cos Feb 15, 2013 8:15 PM Flag

    Going much higher after AAD & MM020

    CELG is still cheap at .80 PEG vs AMGN & BIIB at 1.2 and 1.3. And on conservative 2016 numbers its 0.4 - so you get the best EPS growth in all of healthcare (and almost all S&P 500) for more than half off. Also Big Apremilast trial detail (Two seperate Phase 3 psoriasis trials) coming Mar 2 at AAD - could add $1 billion to analyst ests if PASI scores, safety and other data are as good as company seems to be indicating with their $1.5 to $2.0 billion in 2017 Apremilast ests - analysts still have to move up significantly once they see detaile data in 2 wks. and then the big MM-020 front line data that Citi said this week could add an AMAZING $3.31-$7.71 of INCREMENTAL EPS when front line MM sales peak in EU. This stock, despite its run, is VASTLY undervalued with many upside items (ests include generic Vidaza like they have for 2 yrs - still none in sight, ests include NO BUYBACKS - billions a yr will continue, ests include little for China,Mexico, Brazil, Russia, Turkey, South Korea Revlimid sales - approvals coming international sales very conservative, ests include only $500 million EU front line in 2017 - most see $3 billion+). Yes, this stock is vastly undervalued.

113.35+3.75(+3.42%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.